We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+1.06%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$355M
AUM Growth
-$58.3M
(-14%)
Cap. Flow
-$49.6M
Cap. Flow
% of AUM
-13.96%
Top 10 Holdings %
Top 10 Hldgs %
19.68%
Holding
1,105
New
222
Increased
181
Reduced
330
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI China ETF
MCHI
|
+$5.54M |
| 2 |
iShares MSCI Global Metals & Mining Producers ETF
PICK
|
+$4.8M |
| 3 |
Visa
V
|
+$4.5M |
| 4 |
Zoetis
ZTS
|
+$2.31M |
| 5 |
Wells Fargo
WFC
|
+$2.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$24.9M |
| 2 |
Ferrari
RACE
|
+$19.1M |
| 3 |
CNH
CNH Industrial
CNH
|
+$12.3M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$8.23M |
| 5 |
UBS Group
UBS
|
+$5.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 18.09% |
| 2 | Technology | 16.07% |
| 3 | Consumer Discretionary | 9.4% |
| 4 | Healthcare | 9.16% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
AdvisorShares Pure US Cannabis ETF
MSOS
$969M
| $30.5K | 0.01% |
1,460
-35,000
| -96% | -$764K |
|
627
Cigna
CI
$74.1B
| $30.2K | 0.01% |
126
+124
| +6,200% | +$29K |
|
628
LyondellBasell Industries
LYB
$21B
| $29.8K | 0.01% |
290
| – | – |
|
|
GOEV
629
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $29.7K | 0.01% |
12
-1
| -8% | -$2.75K |
|
|
RCS
630
PIMCO Strategic Income Fund
RCS
$233M
| $28.7K | 0.01% |
4,876
-6,690
| -58% | -$41.2K |
|
631
Sabre
SABR
$936M
| $28.2K | 0.01% |
2,466
+233
| +10% | +$2.28K |
|
|
HOLX
632
DELISTED
Hologic
HOLX
| $27.3K | 0.01% |
355
-12
| -3% | -$863 |
|
633
Stryker
SYK
$109B
| $27.3K | 0.01% |
+102
| New | +$26.4K |
|
634
NeoGenomics
NEO
$2.43B
| $27.1K | 0.01% |
2,227
-1,533
| -41% | -$32.3K |
|
635
iShares Global Tech ETF
IXN
$9.22B
| $26.9K | 0.01% |
464
+42
| +10% | +$2.42K |
|
|
PCN
636
PIMCO Corporate & Income Strategy Fund
PCN
$853M
| $26.8K | 0.01% |
1,700
| – | – |
|
637
Alaunos Therapeutics
TCRT
$3.25M
| $26.5K | 0.01% |
+271
| New | +$34.8K |
|
638
iShares Global REIT ETF
REET
$4.75B
| $26.3K | 0.01% |
901
+82
| +10% | +$2.34K |
|
639
Cooper Companies
COO
$10.4B
| $26.3K | 0.01% |
252
-20
| -7% | -$2.01K |
|
640
HP
HPQ
$29.5B
| $26.3K | 0.01% |
724
-39
| -5% | -$1.44K |
|
641
TripAdvisor
TRIP
$1.05B
| $26.3K | 0.01% |
+969
| New | +$25.8K |
|
642
BP
BP
$117B
| $25.5K | 0.01% |
866
+85
| +11% | +$2.59K |
|
643
iShares US Financial Services ETF
IYG
$2.15B
| $25.4K | 0.01% |
423
| – | – |
|
|
CTXS
644
DELISTED
Citrix Systems Inc
CTXS
| $25.4K | 0.01% |
252
| – | – |
|
645
Valero Energy
VLO
$116B
| $24.9K | 0.01% |
+245
| New | +$21.3K |
|
646
State Street
STT
$50.2B
| $24K | 0.01% |
+276
| New | +$25.6K |
|
647
Tilray
TLRY
$552M
| $23.9K | 0.01% |
+307
| New | +$19.2K |
|
648
iShares Global Utilities ETF
JXI
$294M
| $23.5K | 0.01% |
357
+35
| +11% | +$2.19K |
|
649
Virgin Galactic
SPCE
$444M
| $23.5K | 0.01% |
+119
| New | +$22.2K |
|
650
NewtekOne
NEWT
$343M
| $23.2K | 0.01% |
+870
| New | +$23.5K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q1 2022 Portfolio in Review
As of Q1 2022, Exane Derivatives held 1,105 positions worth $355M, down 14% from $413M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Exane Derivatives withdrew a net $49.6M in Q1 2022, closing 90 positions and reducing 330 holdings. Its most notable exit was iShares S&P 500 Value ETF, an estimated $8.23M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 18% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Exane Derivatives opened a new position in Visa worth $4.62M.
- Exane Derivatives's largest Q1 2022 buy was Visa: 20,811 shares worth $4.62M.
- Exane Derivatives added most to iShares MSCI China ETF in Q1 2022, an estimated $5.54M increase.
- Exane Derivatives's biggest Q1 2022 reduction was Stellantis, cutting an estimated $24.9M.
- Exane Derivatives fully exited iShares S&P 500 Value ETF in Q1 2022, selling an estimated $8.23M.
- Exane Derivatives's ten largest holdings make up 20% of its $355M portfolio in Q1 2022.
- Exane Derivatives opened 222 new positions and closed 90 in Q1 2022.
- Exane Derivatives's portfolio value fell 14% quarter-over-quarter to $355M.
Based on Exane Derivatives's 13F filing for Q1 2022, filed 22 Apr 2022.